Business Wire

Sisvel Enforces 3G Patents at IFA 2016 for Its 3G Licensing Program

Del

Notwithstanding efforts in contacting the companies to offer them a license agreement under the 3G Standard Essential Patents (SEPs), faced with complete unresponsiveness, Sisvel was left with no alternatives to taking enforcement actions against a Chinese and a Taiwanese company exhibiting telephones and mobile phones at the IFA 2016 fair in Berlin. The Regional Court of Berlin granted preliminary injunctions and ordered the seizure of all products making use of the 3G SEPs that Sisvel licenses through its subsidiary 3G Licensing S.A.
“We are a negotiation first licensing administrator”, stated Marcello Dini, Program Manager of the 3G licensing program, “however, to secure FRAND conditions and a level playing field for all the users of the patented technology, in these two cases we were left with no other choice than enforcing the 3G SEPs which are owned by Sisvel’s subsidiary 3G Licensing S.A.” concluded Marcello Dini.
Protection of intellectual property, just like that of real property, is based on the very basic principle that those who invest in the creation of an asset or those who own it deserve protection. Unfortunately, many companies that manufacture or sell products start doing so without considering the rights of third parties, even when they know that these products incorporate technologies invented and patented by others. Sisvel is dedicated to protect inventors, securing a revenue stream to support their research and development activities and fostering a self-sustaining cycle that, if not fully, can at least partially fund innovation.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160907006304/en/

Sisvel enforces 3G Patents at IFA 2016 :Telephones and mobile phones seized at the booths of Chinese ...

Sisvel enforces 3G Patents at IFA 2016 :Telephones and mobile phones seized at the booths of Chinese and Taiwanese exhibitors (Photo: Sisvel)

The 3G SEPs included in Sisvel’s licensing program cover technologies used in a wide range of mobile communication devices and services and have been deemed to be essential to 3GPP’s UMTS standard. Additional information regarding Sisvel’s 3G licensing program and its licensors can be obtained from http://www.3g-licensing.com/ or by sending an e-mail to info@3G-licensing.com

About Sisvel

Started in 1982 when Sisvel S.p.A. was founded in Italy, the Sisvel Group has become a world leader in managing intellectual property and maximizing the value of patent rights. The Sisvel Group is global in scope and reach, with subsidiaries in Italy (Sisvel and Sisvel Technology in None Torinese), the United States (Sisvel US and Audio MPEG in Metropolitan Washington, DC), China (Sisvel Hong Kong), Japan (Sisvel Japan in Tokyo), Germany (Sisvel Germany in Stuttgart), Luxembourg (Sisvel International), and the United Kingdom (Sisvel UK in London), with over one hundred professionals worldwide with engineers, legal, and licensing expertise. Sisvel has a long history of managing successful patent portfolios including those related to the audio compression standards known as MP3 and MPEG Audio, and widespread technologies such as OSD (On Screen Display), ATSS (Automatic Tuning & Sorting System), and WSS (Wide Screen Signalling - for automatic switching of television image formats). Sisvel currently operates patent pools and joint licensing programs for the DVB-T, DVB-T2, LTE/LTE-A and Wi-Fi standards, together with its Sisvel Wireless licensing program and is in the process of creating a new licensing program for DVB-C2.

For additional information, please visit: www.sisvel.com

Contact information

Media Contact
Sisvel Group
Veronica Pugi, Tel: + 39 011 990 4114
Senior Communications Officer
veronica.pugi@sisvel.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom